Anthropic CEO Dario Amodei breaks silence: AI will cure most diseases in 5-10 years, as IPO valuation hits $2 trillion
新智元 · wechat · 2026-08-16
Ahead of a potential record-breaking IPO (valuation up to $2 trillion), Anthropic CEO Dario Amodei published a rare long-form response to Silicon Valley's criticism of his company's power. He rejected the simplistic 'regulation equals regulatory capture' narrative, emphasized the need for institutional constraints, and revealed Anthropic's aggressive push into biomedical AI, predicting AI will cure most human diseases within 5-10 years. Citing his father's death from hepatitis C, he argued AI must genuinely save lives to earn public trust. Anthropic's annualized revenue surged from $1B in Jan 2025 to $47B in May 2026, with 32% enterprise API market share, surpassing OpenAI.
More from AGI Musings
- Machine consciousness contributor Jeff Sebo asks: should we save an ant? — cccalum · 2026-10-03
- Researcher puzzles over why he rejects model personhood while other smart people embrace it — _arohan_ · 2026-10-03
- AI swarms may have added 10-40% effective compute to GPU clusters in six months — 1a3orn · 2026-10-02
- Follow-up: the optimization windfall should be smaller at the frontier — 1a3orn · 2026-10-02
- Facebook feed is now majority AI content, and most of it is hard to spot — stvlsn · 2026-10-02
- AI-driven layoffs may destroy compounding 'intelligence capital', argues fintech analyst — mikeflache · 2026-10-02